SI0804479T1 - Metoda zdravljenja sladkorne bolezni z uporabo kgf - Google Patents

Metoda zdravljenja sladkorne bolezni z uporabo kgf

Info

Publication number
SI0804479T1
SI0804479T1 SI9530728T SI9530728T SI0804479T1 SI 0804479 T1 SI0804479 T1 SI 0804479T1 SI 9530728 T SI9530728 T SI 9530728T SI 9530728 T SI9530728 T SI 9530728T SI 0804479 T1 SI0804479 T1 SI 0804479T1
Authority
SI
Slovenia
Prior art keywords
kgf
diabetes mellitus
treating diabetes
mammals
pharmaceutical compositions
Prior art date
Application number
SI9530728T
Other languages
English (en)
Inventor
Sharon Lea Aukerman
Glenn Francis Pierce
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SI0804479T1 publication Critical patent/SI0804479T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI9530728T 1994-10-13 1995-10-12 Metoda zdravljenja sladkorne bolezni z uporabo kgf SI0804479T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32347594A 1994-10-13 1994-10-13
US32334094A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
EP95934808A EP0804479B1 (en) 1994-10-13 1995-10-12 Method of treating diabetes mellitus using kgf
PCT/IB1995/000992 WO1996011950A1 (en) 1994-10-13 1995-10-12 Method of treating diabetes mellitus using kgf

Publications (1)

Publication Number Publication Date
SI0804479T1 true SI0804479T1 (sl) 2006-12-31

Family

ID=27406268

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9530728T SI0804479T1 (sl) 1994-10-13 1995-10-12 Metoda zdravljenja sladkorne bolezni z uporabo kgf
SI9530654T SI0785948T1 (sl) 1994-10-13 1995-10-12 Analogi keratinocitnega rastnega faktorja

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI9530654T SI0785948T1 (sl) 1994-10-13 1995-10-12 Analogi keratinocitnega rastnega faktorja

Country Status (23)

Country Link
EP (2) EP0785948B1 (sl)
JP (2) JP4426646B2 (sl)
KR (1) KR100278597B1 (sl)
CN (1) CN1168678A (sl)
AT (2) ATE237633T1 (sl)
AU (1) AU3707795A (sl)
BG (2) BG101392A (sl)
BR (2) BR9509269A (sl)
CA (2) CA2202075C (sl)
CZ (3) CZ297328B6 (sl)
DE (2) DE69535264T2 (sl)
DK (2) DK0785948T3 (sl)
EE (2) EE03975B1 (sl)
ES (2) ES2273338T3 (sl)
FI (2) FI971420A (sl)
HU (2) HUT78050A (sl)
NO (2) NO318761B1 (sl)
NZ (2) NZ505502A (sl)
PL (2) PL320484A1 (sl)
PT (2) PT785948E (sl)
SI (2) SI0804479T1 (sl)
SK (2) SK284534B6 (sl)
WO (2) WO1996011950A1 (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197800T1 (de) 1989-01-31 2000-12-15 Jeffrey S Rubin Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
CZ343795A3 (en) 1993-06-29 1996-07-17 Chiron Corp Shortened keratinocyte growth factor /kgf/ exhibiting increased biological activity
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
ES2197926T3 (es) * 1994-10-13 2004-01-16 Amgen Inc. Metodo para purificar factores de crecimiento de queratinocitos.
US6077692A (en) * 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
WO1996034017A1 (en) * 1995-04-27 1996-10-31 Coöperatie Suiker Unie U.A. Inulin derivatives
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
DE69728415T2 (de) * 1996-10-15 2004-08-12 Amgen Inc., Thousand Oaks Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
SI0935652T1 (sl) * 1996-10-15 2004-06-30 Amgen Inc. Proizvodi keratinocit-rastnega faktorja-2
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
ES2297889T3 (es) 1997-07-14 2008-05-01 Bolder Biotechnology, Inc. Derivados de hormona de crecimiento y proteinas relacionadas.
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
KR20010033484A (ko) 1997-12-22 2001-04-25 휴먼 게놈 사이언시즈, 인크. 각질세포 성장 인자-2 제제
US6242666B1 (en) 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
BR122013003013B8 (pt) * 1999-01-14 2021-07-06 Bolder Biotechnology Inc proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
EP1360201A1 (en) * 2001-02-06 2003-11-12 MERCK PATENT GmbH Modified keratinocyte growth factor (kgf) with reduced immunogenicity
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
MXPA04001526A (es) 2001-08-21 2004-05-31 Chiron Corp Composiciones de polipetidos kgf.
US8304387B2 (en) 2004-12-15 2012-11-06 Swedish Orphan Biovitrum Ab (Publ) Therapeutic formulations of keratinocyte growth factor
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5145225A (en) * 1988-07-27 1992-09-08 Muller George M Carpet stretcher
ATE197800T1 (de) * 1989-01-31 2000-12-15 Jeffrey S Rubin Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
CZ285996B6 (cs) * 1993-03-26 1999-12-15 Amgen Inc. Způsob in vitro stimulace produkce nekeratinocytových epithelových buněk a růstový faktor keratinocytů pro léčbu chorob
CZ343795A3 (en) * 1993-06-29 1996-07-17 Chiron Corp Shortened keratinocyte growth factor /kgf/ exhibiting increased biological activity
US5348563A (en) * 1993-06-29 1994-09-20 Honeywell Inc. Air purifying apparatus
GB9315501D0 (en) * 1993-07-27 1993-09-08 Ici Plc Surfactant compositions
JPH09503751A (ja) * 1993-08-02 1997-04-15 プリズム ファーマシュティカルズ，インコーポレイティド 細胞毒性抱合体の単一起源性製剤

Also Published As

Publication number Publication date
BG101392A (en) 1997-10-31
NO971566D0 (no) 1997-04-04
CZ105097A3 (cs) 1998-10-14
ES2196082T3 (es) 2003-12-16
EE9700225A (et) 1998-02-16
NO318761B1 (no) 2005-05-02
ATE237633T1 (de) 2003-05-15
DE69535264T2 (de) 2007-02-01
FI120040B (fi) 2009-06-15
DE69530403D1 (de) 2003-05-22
ES2273338T3 (es) 2007-05-01
BR9509329A (pt) 1997-10-14
SK43197A3 (en) 1999-03-12
NO971568L (no) 1997-06-12
NZ335109A (en) 2000-08-25
DK0804479T3 (da) 2007-01-29
HU226168B1 (en) 2008-05-28
PT804479E (pt) 2007-02-28
NO971568D0 (no) 1997-04-04
PT785948E (pt) 2003-09-30
ATE342278T1 (de) 2006-11-15
AU681546B2 (en) 1997-08-28
SI0785948T1 (sl) 2003-08-31
EP0785948B1 (en) 2003-04-16
FI971420A0 (fi) 1997-04-04
JPH10507080A (ja) 1998-07-14
NZ505502A (en) 2005-01-28
EE03975B1 (et) 2003-02-17
CZ98197A3 (cs) 1998-11-11
CZ297329B6 (cs) 2006-11-15
BG101408A (en) 1997-12-30
KR100278597B1 (ko) 2001-01-15
DK0785948T3 (da) 2003-08-04
DE69530403T2 (de) 2003-10-30
PL320484A1 (en) 1997-09-29
CZ297328B6 (cs) 2006-11-15
AU3707795A (en) 1996-05-06
FI971420A (fi) 1997-04-04
JP4216329B2 (ja) 2009-01-28
BG63167B1 (bg) 2001-05-31
WO1996011949A3 (en) 1996-12-12
AU3708395A (en) 1996-05-06
BR9509269A (pt) 1997-12-23
CA2202075C (en) 2003-12-09
JPH10507193A (ja) 1998-07-14
CN1168678A (zh) 1997-12-24
EP0785948A1 (en) 1997-07-30
PL319784A1 (en) 1997-08-18
SK284534B6 (sk) 2005-06-02
CA2201940A1 (en) 1996-04-25
SK45597A3 (en) 1999-02-11
WO1996011950A1 (en) 1996-04-25
CA2202075A1 (en) 1996-04-25
JP4426646B2 (ja) 2010-03-03
EP0804479B1 (en) 2006-10-11
FI971536A (fi) 1997-06-09
EP0804479A1 (en) 1997-11-05
NO971566L (no) 1997-04-14
HUT78058A (hu) 1999-07-28
WO1996011949A2 (en) 1996-04-25
EE9700081A (et) 1997-10-15
HUT78050A (hu) 1999-07-28
FI971536A0 (fi) 1997-04-11
CA2201940C (en) 2009-05-12
DE69535264D1 (de) 2006-11-23
PL182888B1 (pl) 2002-03-29

Similar Documents

Publication Publication Date Title
SI0804479T1 (sl) Metoda zdravljenja sladkorne bolezni z uporabo kgf
AU1128297A (en) Composition for treating pain
AU3040795A (en) Method and composition for treating intestinal wounds or ulcers
GB9410639D0 (en) Method of improving fertilization
AU1829195A (en) Energy formulation
AU7793791A (en) Pharmaceutical composition for use in treating pain
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
HU9503331D0 (en) Process for treating ill people with oxygen
PL328949A1 (en) Method of treatng excessive aggression
DE69534740D1 (en) Analoge des thymosin alpha 1
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
AU3597695A (en) Improved method and composition for the treatment of ulcers
AU6459996A (en) Composition and method for treating diabetes
IL101313A0 (en) Compositions and methods for increasing oxygen delivery to tissue
GB9421321D0 (en) Composition for the treatment of gastro-duodenal ulcers
HUT72420A (en) Composition for treating diabetes and process for treating the same
HUT73782A (en) Creme for treating feet of patients in diabetes